Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-252-9 | CAS number: 1315-01-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: genome mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted with a similar substance according to standard methods and GLP, therefore it is considered reliable and relevant, but in isolation, not adequate for classification. Read-Across
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Tin Sulfide CAS 1314-95-0
- IUPAC Name:
- Tin Sulfide CAS 1314-95-0
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Bio Test s.r.o., Pod Zámkem 279, Konárovice, Crech Republic
- Age at study initiation: 8-10 weeks on delivery
- Weight at study initiation: Males 250 g, Females 170 g
- Assigned to test groups randomly: Yes, under following basis: the animals were sorted according to the body weight and randomly allocated to the dose group taking animals from each range group.
- Fasting period before study: Not provided
- Housing: 2-3 animals of the same sex/cage in Macrolon 2000P cages (Tecniplast), Tier Wohl (JRS, Germany) was used as bedding
- Diet (e.g. ad libitum): Standard pelletized rodent diet of monitored quality Feed NOE H4 (Racio Breclav, CZ);Feed containers were changed and sanitized at least once a week
- Water (e.g. ad libitum): Water of monitored quality, ad libitumWater containers were changed and sanitized at least once a week
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): Not provided
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: methylcellulose 0.5%
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Each animal in treated groups received the appropriate dose of Test item suspension orally by gavage in the volume of 1 mL per 100 g body weight. The animals in the negative control group received the appropriate volume of saline solution by the same way. The animals in the positive control group were administered cyclophosphamide solution at the dose of 20 mg/kg by a single intraperitoneal application in the volume of 1 mL per 100 g body weight.
The following procedure was adopted for the preparation of a homogenous suspension: at first the weighed amount of the respective substance was ground in a grinding mortar with a small volume of carrier liquid. Then the content of the mortar was transferred into a calibrated vessel. Another amount of carrier liquid was poured into the mortar, stirred and the mortar with the pestle was rinsed, the rinsing liquid was added into the same calibrated vessel. This rinsing procedure was repeated once more. Then the volume in the calibrated vessel was made up with the carrier liquid to the required volume and mixed. Immediately before the application, the suspension was again stirred by means of an electromagnetic stirrer. - Duration of treatment / exposure:
- Duration of administration was 10-20 s
- Frequency of treatment:
- single administration (p.o.; i.p.)
- Post exposure period:
- 24 hours; 48 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (actual dose received)
- Remarks:
- single exposure
- Dose / conc.:
- 500 mg/kg bw/day (actual dose received)
- Remarks:
- single exposure
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Remarks:
- single exposure
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- Remarks:
- single exposure
- No. of animals per sex per dose:
- 10
- Control animals:
- other: negative control:0.9% sodium chloride “Braun” oral gavage in the volume of 1 mL per 100 g body weight... (see attached file)
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s):
- Route of administration: intraperitoneal
- Doses / concentrations: 20 mg/kg bw
Examinations
- Tissues and cell types examined:
- Bone marrow cells (mean number of NCPE, PCE, NCE and proportion of immature erythrocytes)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Dose selection information from literature:
Insoluble tin compounds were demonstrated to have negligible toxic effects in rats when administered for 28 days in the diet. Rats were fed on diets containing 0.0, 0.03, 0.10, 0.30 or 1.00% of Tin sulfide, which did not result in adverse effects on mortality, body weight change, diet utilization, measurements of blood, urine and biochemical parameters, organ weights and gross and micropathology. The amount of 1% in the diet was calculated to correspond with approximately 670 mg/ kg body weight/day on average basis.
References:
-WHO Food Additives Series Vol:46 (2001) pp 307-60;
-de Groot A.P., Feron V. J., Til H. P. Short-term toxicity studies on some salts and oxides of tin in rats. Food and Cosmetics Toxicology, Volume 11, Issue 1, February 1973, Pages 19-30.
Dose selection information from other studies:
Information became available from an oral DRF study in preparation of the 3-month toxicity study in the rat (Exp. 32/09/C Bio Test) and from the in vitro chromosome aberration toxicity study in human peripheral lymphocytes (Exp. 31/09/C Bio Test). Based upon the information of these studies, and taking into account the literature information, dose levels were amended to 500, 1000 and 2000 mg/kg bw. The limit dose of 2000 mg/kg bw was included in this study.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
-The animals were exposed to Test item and control items by single administration.
-One half of the animals from each group were sacrificed by cervical dislocation in ether anaesthesia 24 hours after the administration and the other half of animals were sacrificed 48 hours after the administration.
DETAILS OF SLIDE PREPARATION:
During the necropsy the bone marrow was extracted from femur using bovine serum into a labeled test tube. The cells were centrifuged (1000 rpm for 10 min). The supernatant was removed and the sediment was resuspended in approx. 4 drops of bovine serum. Smear preparations from this suspension were made in duplo for each animals and fixed with methanol for 5 min and then stained with Giemsa-Romanowski (1:10) for 15-20 min.
All the slides were independently coded before blind microscopic analysis.
METHOD OF ANALYSIS:
At least 2000 polychromatic (immature) erythrocytes per animal were scored for the incidence of micronuclei under the microscope. The proportion of polychromatic (immature) among total (immature + mature or polychromatic + normochromatic) erythrocytes were determined for each animals by counting a total of at least 200 erythrocytes. - Evaluation criteria:
- At least 2000 polychromatic (immature) erythrocytes per animal were scored for the incidence of micronuclei under the microscope. The proportion of polychromatic (immature) among total (immature + mature or polychromatic + normochromatic) erythrocytes were determined for each animal by counting a total of at least 200 erythrocytes.
- Statistics:
- The analyzed data were tested for normality (Kolmogorov–Smirnov test) and homogeneity of variance
(Bartlett’s test).
The data for males and females were separately analyzed using ANOVA followed by Dunnett’s Multiple Comparison Test. The F-test in the ANOVA tests whether there are any significant differences amongst the means at the 95.0 % confidence level.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Tin sulfide does not produce micronuclei in the immature erythrocytes in the conditions of the test.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
No increase was found in the frequency of micronucleated polychromatic erythrocytes in treated animals as indication of induced chromosome damage. Tin sulfide does not induce damage to the chromosomes or the mitotic apparatus of erythroblasts. - Executive summary:
The purpose of the micronucleus test is to identify substances that cause cytogenetic damage which results in the formation of micronuclei containing lagging chromosome fragments or whole chromosomes.
For this study 50 male and 50 female rats (8-12 weeks old) were used, divided into 5 groups: dose group D1 (500 mg/kg), D2 (1000 mg/kg), D3 (2000 mg/kg), group C (negative control) and group CP (positive control-cyclophosphamide), each including 20 animals t 10 males and 10 females). Samples of bone marrow were taken at 24 and 48 hours after the single administration.
Each animal in treated groups received the appropriate dose of Test item suspension orally by gavage in the volume of 1 mL per 100 g body weight. The animals in the negative control group received the appropriate volume of saline solution by the same way. The animals in the positive control group were administered cyclophosphamide solution at the dose of 20 mg/kg by a single intraperitoneal application in the volume of 1 mL per 100 g body weight.
All the rats were observed for clinical signs, morbidity or mortality during acclimation, before administration and after administration in time points 0 (immediately after dosing), 0.5, 1, 2, 4 and 24 hours post-dose and then before necropsy.
All the rats were individually weighed at delivery and prior to the administration in order to calculate dose levels.
No changes in health status and condition of the animals in any of the groups were recorded during the acclimation and during the study.
No significant changes of mean body weight were observed in the animals during the study.
All the values of number of normochromatic erythrocytes with micronuclei in all dose groups (D1, D2 and D3) were within the reference range for negative control group. No statistically significant higher values of number of normochromatic erythrocytes with micronuclei in any of the dose groups (up to 11 of micronuclei) as compared to negative control group (up to 13 micronuclei) were noted. Statistically significant differences were observed in the positive control group (normochromatic erythrocytes with micronuclei -up to 38 of micronuclei) as compared to control group.No increase was found in the frequency of micronucleated polychromatic erythrocytes in treated animals as indication of induced chromosome damage. Tin sulfide does not induce damage to the chromosomes or the mitotic apparatus of erythroblasts.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.